mRNA Influenza Vaccines Market Size, Share & Industry Analysis, By Product Type (Standalone and Combination Vaccines), By Indication (Seasonal Influenza, Pre-pandemic/Pandemic Influenza, and Broad-Spectrum/Universal Influenza), By Technology (Conventional Non-Replicating mRNA, Self-Amplifying mRNA, and Trans-Amplifying RNA), By Valency (Monovalent, Trivalent, and Quadrivalent), By Age Group (Pediatric, 18-49, 50-64, and 65+ Years), By Distribution Channel (Government Health Programs, Hospitals & Vaccination Clinics, and Retail Pharmacies & Drug Stores), and Regional Forecast, 2026-2034